Vicarious Surgical INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
Vicarious Surgical Inc. is seeking stockholder approval for a reverse stock split to boost its share price and facilitate a potential Nasdaq Capital Market listing following its delisting from the NYSE.
OQB
Vicarious Surgical Inc. is holding a special meeting on January 9, 2026, to seek stockholder approval for the exercise of common warrants to purchase up to 2,300,000 shares of Class A common stock.
OQB
Vicarious Surgical Inc. has filed a definitive proxy statement with the U.S. Securities and Exchange Commission.
OQB
Vicarious Surgical is holding its 2025 annual meeting virtually on June 27, 2025, to elect directors, approve an amendment to the 2021 Equity Incentive Plan, and ratify the appointment of Deloitte & Touche LLP as its independent auditor.
OQB
Vicarious Surgical Inc. has filed a definitive proxy statement with the SEC.
OQB
Vicarious Surgical is seeking stockholder approval for a reverse stock split to maintain its NYSE listing and an amendment to its equity incentive plan to attract and retain key personnel.